ARCHIVES

Only 20% of Doctors Advise CRC According To Guidelines

This article is from The Cancer Letter archive.

Vol. 33 No. 10 | October 29, 2010

Download PDF Visit The Full Archive

Related Articles

Top Management Shifts At Bristol-Myers Squibb Oncology, R&D Units

October 6, 1995

Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis

December 27, 2013

National Lung Cancer Partnership Announces Annual Grant Competition

August 9, 2013

Cancer Programs Close Amid Gridlock

October 4, 2013

New Trial For Metastatic Colorectal Cancer Testing Vaccine-Chemotherapy Combination

March 29, 2002

For Frederick, Unseat Program Resources Inc.

March 3, 1995